IPD Analytics LLC

IPD Analytics, LLC provides independent research and analysis to the financial and healthcare communities on patent litigation and related issues affecting the pharmaceutical, medical-technology and Technology/Media/Telecommunications (TMT) industries. Based on our unique knowledge and understanding of patent litigation in these key industry sectors, we offer powerful tools and strategic intelligence for predicting the probable outcome of each case and forecasting the launch of new generic drugs and other competitive products and technology. Institutional investors depend on IPD Analytics, LLC to: (a) research and analyze ongoing patent litigation in the pharmaceutical, med-tech and TMT industries; and (b) anticipate court decisions with a significant binary impact on the stock prices of the parties. Pharmacy retailers, wholesaler-distributors, pharmacy benefit managers, and managed-care organizations use or our unique tools and analysis to generate increased profits and cost savings from improved generic forecasting, pharmaceutical contracting, premium-setting, and inventory management. IPD Analytics, LLC offers its subscribers from the investment and healthcare sectors the most comprehensive and insightful analysis of pharmaceutical, medical-technology and TMT patent litigation available today. Through critical tools and strategic intelligence for predicting the probable outcome of patent litigation and forecasting the launch of new generic drugs and other competing products and technologies, our subscribers gain a valuable competitive advantage, higher profits, and increased cost savings.